mAbxience Research

NCT06687369

Phase 3, Active, not recruiting, 2024, 726 people, 13 Nov 2024, clinicaltrials.gov

NCT05338086

Phase 3, Completed, 2022, 558 people, 20 Apr 2022, clinicaltrials.gov

NCT02069704

Phase 1, Completed, 2014, 142 people, 24 Feb 2014, clinicaltrials.gov